Cosmetology is the study of application of beauty treatments such as hair care, skincare, cosmetic surgeries, etc. The cosmetology market size is majorly driven by the cosmetic surgical procedures (plastic surgeries) such as hair transplant, facelift, and liposuction. Increasing inclination of population towards aesthetic appearance is propelling demand for body enhancements, which in turn is driving the cosmetology market growth. Fillers and Botox are the most popular products in cosmetic surgery for face enhancement. Irrespective of the gender cosmetic surgery is popular among the population.

Global Cosmetology Market: Drivers

Cosmetic surgeries has become one of the most performed procedures every year. The global cosmetology market revenue is expected to witness significant growth, owing to increasing demand for different types of cosmetic surgeries. For instance, according to American Society of Plastic Surgeons (ASPS) 2017 reports, around 17.5 million cosmetic surgeries were performed in 2017, in the U.S. among which breast augmentation, liposuction, and nose reshaping were the top three procedures.

Furthermore, cosmetology market is witnessing growth, owing to increasing demand for the skin care products. Botox surgeries are mostly preferred by women, as it helps to reduce the wrinkles and maintain youthful skin for longer period of time. According to American Society of Plastic Surgeons (ASPS) 2017 reports, around 7.2 million Botulinum toxin type A, nonsurgical aesthetic treatments were performed in the U.S.

Global Cosmetology Market: Restraints

The cosmetology market size is restrained by the potential side effects and failures of the cosmetic surgeries such as Botox injections, lip fillers, breast augmentation etc. According to Food and Drug Administration (FDA), some of the serious side effects caused by Botox listed in 2016, include problems in swallowing, speaking, or breathing. Other side effects are tiredness, headache, dry eyes, urinary tract infection, and allergic reactions. Failures of cosmetic surgeries also hamper the cosmetology market growth. According to a study published in National Center for Biotechnology Information in 2016, the overall 10 year rupture rate of silicone breast implants is 13% in the U.S.

Global Cosmetology Market: Regional Analysis

North America held the dominant position in the cosmetology market in 2017, owing to emerging technologies used for cosmetic surgeries, which are contributing to cosmetology market growth. For instance, laser surgeries are very popular for the removal of blemishes, scars, facial hairs etc. According to the American Society for Dermatologic Surgery (ASDS), around 3.2 million procedures were performed using laser, light and energy-based devices for skin resurfacing in 2017 in the U.S.

Asia pacific is witnessing significant growth in cosmetology market, owing to the rising demand for facial reconstruction surgeries in countries such as China, Japan, and South Korea. Facial reconstruction surgeries such as rhinoplasty (nose job), eyelid lift, and chin reconstruction are the most popular surgeries. According to International Society of Aesthetic Plastic Surgery (ISAPS) 2014 reports, based on the population of South Korea, roughly 20 per 1,000 people have had undergone some type of plastic surgery, reporting the highest ratio of procedures per capita in South Korea

Global Cosmetology Market: Competitive Landscape

Key players operating in the global cosmetology market include GC Aesthetics, Mentor Worldwide LLC, Sientra Inc., Zimmer Holdings Inc., 3M Health Care, Allergan, Inc., Implantech Associates Inc., Institut Straumann AG, Nobel Biocare Holding AG, and Spectrum Designs Medical.

Global Cosmetology Market: Taxonomy

The global cosmetology market is segmented on the basis of procedure type, application and region.

By Procedure Type

Surgical
Non-Surgical

By Application

Breast Enhancement
Facial Contouring
Facial Rejuvenation
Body Contouring
Skin Rejuvenation
Hair Transplant
Buttock Enhancement

By Region

North America
Latin America
Europe
Asia Pacific
Middle East
Africa

About Author

Ghanshyam Shrivastava - With over 20 years of experience in the management consulting and research, Ghanshyam Shrivastava serves as a Principal Consultant, bringing extensive expertise in biologics and biosimilars. His primary expertise lies in areas such as market entry and expansion strategy, competitive intelligence, and strategic transformation across diversified portfolio of various drugs used for different therapeutic category and APIs. He excels at identifying key challenges faced by clients and providing robust solutions to enhance their strategic decision-making capabilities. His comprehensive understanding of the market ensures valuable contributions to research reports and business decisions.

Ghanshyam is a sought-after speaker at industry conferences and contributes to various publications on pharma industry.